• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Monday, October 26, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Cancer

Rare EGFR variant linked to sharply elevated lung cancer risk

by
October 26, 2026
in Cancer
Reading Time: 2 mins read
0
Rare EGFR variant linked to sharply elevated lung cancer risk

Rare EGFR variant linked to sharply elevated lung cancer risk

Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A rare inherited variant in the EGFR gene was associated with substantially higher lung cancer risk in a peer-reviewed study published in Science , with the strongest association observed among people who had never smoked. Jaclyn LoPiccolo and colleagues analyzed genetic data from 3.37 million people of European ancestry and estimated that carriers of the germline EGFR T790M mutation had about 25 times the overall risk of lung cancer. Among never-smokers, the estimated risk was approximately 62 times higher for carriers than for noncarriers.

The study evaluated the association between inherited EGFR T790M and lung cancer in a population large enough to provide more reliable estimates for a mutation that is extremely rare. T790M can be inherited and has been linked to increased susceptibility to lung adenocarcinoma, particularly when it occurs together with a second cancer-driving EGFR mutation. The investigators found no significant links between the inherited variant and other cancer types or respiratory conditions.

Their analysis therefore identified a risk association that was especially pronounced for lung cancer in people without a smoking history, rather than a general association with multiple forms of cancer or respiratory disease. Smoking was associated with roughly a fourfold increase in lung cancer risk in the same analysis. That estimate was lower than the association observed for inherited EGFR T790M, but the comparisons addressed different exposure groups: smoking was associated with increased risk across the study population, whereas the T790M association was particularly strong among never-smokers.

The researchers’ estimates show that inherited EGFR T790M was associated with a larger relative risk than smoking in these data. The results do not establish that every carrier will develop lung cancer, nor do they determine the absolute probability of cancer for an individual carrying the variant. Genetic data also revealed a pronounced geographic concentration of T790M carriers in the Southern Appalachian region of the United States, especially in Tennessee and Alabama.

LoPiccolo and colleagues suggested that the mutation arose in Europe and was brought to the Southern Appalachian region by British and Irish settlers during the colonial era, after which it became more common among relatively isolated populations. This proposed history is an interpretation of the allele’s distribution and the populations in which it was concentrated, rather than a directly documented lineage tracing the mutation through particular families. The findings identify inherited EGFR T790M as a distinct genetic factor associated with lung cancer risk among never-smokers.

The analysis was restricted to people of European ancestry, so the estimated risks may not apply equally to populations with other ancestry backgrounds. Together, the results point to an inherited risk factor that is associated with an especially pronounced elevation in lung cancer risk among people who do not smoke.

Subject of Research: Inherited EGFR T790M mutations and lung cancer risk in never-smokers

Article Title: Rare inherited genetic mutation raises lung cancer risk in non-smoker humans

Article References: Rare inherited genetic mutation raises lung cancer risk in non-smoker humans. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: EGFR T790M, lung cancer, never-smokers, inherited mutations, germline variation, cancer genetics, Southern Appalachia, lung adenocarcinoma, Rare, inherited, genetic, mutation

News Source: Nathaniel Bowman. (October 26, 2026). Rare EGFR variant linked to sharply elevated lung cancer risk. Scienmag.

Tags: cancer geneticsEGFR T790Mgeneticgermline variationinheritedinherited mutationslung adenocarcinomalung cancermutationnever-smokersrareSouthern Appalachia
Share12Tweet7Share2ShareShareShare1

Related Posts

Alliance webinar showcases latest cancer research from 2026 ASCO Meeting

Alliance webinar showcases latest cancer research from 2026 ASCO Meeting

October 26, 2026
Preclinical thyroid cancer study restores CAR-T target with targeted drugs

Preclinical thyroid cancer study restores CAR-T target with targeted drugs

October 26, 2026

Machine learning identifies leukemia drug candidates and vulnerable target

October 26, 2026

Circulating B cells linked to immunotherapy-related colitis risk

October 26, 2026

POPULAR NEWS

  • Scoping review finds inconsistent acceptability reporting in healthcare research

    Scoping review finds inconsistent acceptability reporting in healthcare research

    29 shares
    Share 12 Tweet 7
  • Rare EGFR variant linked to sharply elevated lung cancer risk

    29 shares
    Share 12 Tweet 7
  • A multi-dimensional SWOT-based strategic planning framework for tertiary public hospitals during the 15th Five-Year Plan period

    29 shares
    Share 12 Tweet 7
  • Thai drinkers with higher AUDIT-C risk less likely to plan Lent abstinence

    29 shares
    Share 12 Tweet 7

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Rare EGFR variant linked to sharply elevated lung cancer risk

Scoping review finds inconsistent acceptability reporting in healthcare research

A multi-dimensional SWOT-based strategic planning framework for tertiary public hospitals during the 15th Five-Year Plan period

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 85 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.